share_log

Morgan Stanley Maintains Overweight on LifeStance Health Gr, Raises Price Target to $10

Morgan Stanley Maintains Overweight on LifeStance Health Gr, Raises Price Target to $10

摩根士丹利維持對LifeStance Health Gr的增持,將目標股價上
Benzinga ·  2023/05/11 08:26

Morgan Stanley analyst Ricky Goldwasser maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $8 to $10.

摩根士丹利分析師瑞奇·戈德瓦瑟維持LifeStance Health Gr(納斯達克股票代碼:LFST)的增持,並將目標股價從8美元上調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論